<p>CapsoVision, Inc.（纳斯达克代码：CV - 获取免费报告）在三月份的空头头寸大幅增长。截至 3 月 13 日，空头头寸总计为 553,348 股，比 2 月 26 日的 409,160 股增长了 35.2%。根据平均每日交易量 199,118 股，目前的覆盖天数比率为 2.8 天。大约 1.2% 的公司股份被卖空。</p>
<h2>分析师设定新的价格目标</h2>
<ul>
<li>3 只被低估的软件股票准备反弹</li>
</ul>
<p>多位股票分析师最近对该公司发布了报告。华尔街 Zen 在 1 月 10 日的报告中将 CapsoVision 的评级上调至 “持有”。Weiss Ratings 在 12 月 29 日的研究报告中重申了对 CapsoVision 股票的 “卖出（e）” 评级。最后，Benchmark 在周五的研究报告中将 CapsoVision 的目标价格从 14.00 美元下调至 10.00 美元，并为该公司设定了 “投机性买入” 评级。一位研究分析师给予该股票 “强烈买入” 评级，一位给予 “买入” 评级，一位给予 “持有” 评级，还有一位给予 “卖出” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，平均目标价格为 8.50 美元。</p>
<p><strong>阅读我们对 CV 的最新分析</strong></p>
<h2>CapsoVision 下跌 0.3%</h2>
<ul>
<li>隐藏的宝石：3 只价值股值得关注以获取强劲的 2025 年回报</li>
</ul>
<p>在周五的交易时段，纳斯达克 CV 的股票下跌了 0.02 美元，达到 7.51 美元。该股票的交易量为 288,209 股，而其平均交易量为 578,162 股。CapsoVision 的 52 周低点为 3.43 美元，52 周高点为 15.37 美元。该公司的市值为 3.5177 亿美元，市盈率为-3.43。该公司的 50 日移动平均价格为 5.58 美元，200 日移动平均价格为 6.27 美元。</p>
<p>CapsoVision（纳斯达克：CV - 获取免费报告）最后一次发布季度财报是在 3 月 26 日，报告显示该季度每股收益为 0.02 美元。该公司的季度收入为 392 万美元。</p>
<h2>对 CapsoVision 的对冲基金看法</h2>
<ul>
<li>2 只小盘股在牛市中将大放异彩</li>
</ul>
<p>几家机构投资者最近对该公司的持仓进行了调整。Virtu Financial LLC 在第四季度购买了 CapsoVision 的新股份，价值约 128,000 美元。Millennium Management LLC 在第四季度购买了 CapsoVision 的新持仓，价值约 163,000 美元。State Street Corp 在第四季度将其在 CapsoVision 的持股增加了 340.7%。State Street Corp 目前拥有 85,929 股该公司的股票，价值 919,000 美元，此前在上个季度增持了 66,429 股。Wells Fargo &amp; Company MN 在第四季度将其在 CapsoVision 的持仓增加了 66.4%。Wells Fargo &amp; Company MN 目前拥有 6,287 股该公司的股票，价值 67,000 美元，此前在此期间增持了 2,508 股。最后，德意志银行在第四季度购买了 CapsoVision 的新股份，价值约 47,000 美元。</p>
<h2>CapsoVision 公司简介</h2>
<p>（获取免费报告）</p>
<p>CapsoVision, Inc. 纳斯达克：CV 是一家医疗设备公司，专注于用于胃肠道诊断的先进胶囊内窥镜系统。该公司的旗舰产品 CapsoCam® Plus 系统，配备了四个侧视摄像头的可吞咽、无绳胶囊，能够捕捉小肠的高分辨率 360 度图像。通过内部存储图像而不是无线传输数据，CapsoCam Plus 使患者在手术期间能够保持正常的日常活动，并降低信号丢失或图像掉落的风险。</p>
<p>除了胶囊硬件外，CapsoVision 还提供 CapsoCloud®，一个安全的基于云的平台，简化图像检索、存储和报告。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 CapsoVision</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 CapsoVision 吗？</h2>
<p>在你考虑 CapsoVision 之前，你需要听听这个。</p>
<p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而 CapsoVision 并不在名单上。</p>
<p>虽然 CapsoVision 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

<p>CapsoVision, Inc.（纳斯达克代码：CV）在 3 月份的空头头寸显著增加了 35.2%，总计达到 553,348 股。目前空头头寸比率为 2.8 天，卖空股份占比为 1.2%。分析师的评级各不相同，平均目标价格为 8.50 美元。该股票交易价格下跌至 7.51 美元，市值为 3.5177 亿美元。CapsoVision 专注于用于胃肠道诊断的先进胶囊内窥镜系统，提供 CapsoCam® Plus 系统和 CapsoCloud®平台</p>

<p>CapsoVision, Inc. (NASDAQ:CV - Get Free Report) saw a large growth in short interest in the month of March. As of March 13th, there was short interest totaling 553,348 shares, a growth of 35.2% from the February 26th total of 409,160 shares. Based on an average daily volume of 199,118 shares, the days-to-cover ratio is currently 2.8 days. Approximately 1.2% of the company's shares are sold short.</p>
<div class="lb-trans"><p>CapsoVision, Inc.（纳斯达克代码：CV - 获取免费报告）在三月份的空头头寸大幅增长。截至 3 月 13 日，空头头寸总计为 553,348 股，比 2 月 26 日的 409,160 股增长了 35.2%。根据平均每日交易量 199,118 股，目前的覆盖天数比率为 2.8 天。大约 1.2% 的公司股份被卖空。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新的价格目标</h2>
</div><ul>
<li>3 Under-the-Radar Software Stocks Ready to Bounce</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只被低估的软件股票准备反弹</li>
</ul>
</div><p>A number of equities analysts recently issued reports on the company. Wall Street Zen upgraded CapsoVision to a &#34;hold&#34; rating in a report on Saturday, January 10th. Weiss Ratings reiterated a &#34;sell (e)&#34; rating on shares of CapsoVision in a research report on Monday, December 29th. Finally, Benchmark lowered their target price on shares of CapsoVision from $14.00 to $10.00 and set a &#34;speculative buy&#34; rating for the company in a research note on Friday. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $8.50.</p>
<div class="lb-trans"><p>多位股票分析师最近对该公司发布了报告。华尔街 Zen 在 1 月 10 日的报告中将 CapsoVision 的评级上调至 “持有”。Weiss Ratings 在 12 月 29 日的研究报告中重申了对 CapsoVision 股票的 “卖出（e）” 评级。最后，Benchmark 在周五的研究报告中将 CapsoVision 的目标价格从 14.00 美元下调至 10.00 美元，并为该公司设定了 “投机性买入” 评级。一位研究分析师给予该股票 “强烈买入” 评级，一位给予 “买入” 评级，一位给予 “持有” 评级，还有一位给予 “卖出” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，平均目标价格为 8.50 美元。</p>
</div><p><strong>Read Our Latest Analysis on CV</strong></p>
<div class="lb-trans"><p><strong>阅读我们对 CV 的最新分析</strong></p>
</div><h2>CapsoVision Trading Down 0.3%</h2>
<div class="lb-trans"><h2>CapsoVision 下跌 0.3%</h2>
</div><ul>
<li>Hidden Gems: 3 Value Stocks to Watch for Strong 2025 Returns</li>
</ul>
<div class="lb-trans"><ul>
<li>隐藏的宝石：3 只价值股值得关注以获取强劲的 2025 年回报</li>
</ul>
</div><p>Shares of NASDAQ CV traded down $0.02 during trading hours on Friday, reaching $7.51. The stock had a trading volume of 288,209 shares, compared to its average volume of 578,162. CapsoVision has a 52-week low of $3.43 and a 52-week high of $15.37. The firm has a market cap of $351.77 million and a price-to-earnings ratio of -3.43. The business's fifty day moving average price is $5.58 and its two-hundred day moving average price is $6.27.</p>
<div class="lb-trans"><p>在周五的交易时段，纳斯达克 CV 的股票下跌了 0.02 美元，达到 7.51 美元。该股票的交易量为 288,209 股，而其平均交易量为 578,162 股。CapsoVision 的 52 周低点为 3.43 美元，52 周高点为 15.37 美元。该公司的市值为 3.5177 亿美元，市盈率为-3.43。该公司的 50 日移动平均价格为 5.58 美元，200 日移动平均价格为 6.27 美元。</p>
</div><p>CapsoVision (NASDAQ:CV - Get Free Report) last released its quarterly earnings data on Thursday, March 26th. The company reported $0.02 EPS for the quarter. The firm had revenue of $3.92 million for the quarter.</p>
<div class="lb-trans"><p>CapsoVision（纳斯达克：CV - 获取免费报告）最后一次发布季度财报是在 3 月 26 日，报告显示该季度每股收益为 0.02 美元。该公司的季度收入为 392 万美元。</p>
</div><h2>Hedge Funds Weigh In On CapsoVision</h2>
<div class="lb-trans"><h2>对 CapsoVision 的对冲基金看法</h2>
</div><ul>
<li>2 Small-Cap Stocks Set to Shine in a Bull Market</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只小盘股在牛市中将大放异彩</li>
</ul>
</div><p>Several institutional investors have recently made changes to their positions in the company. Virtu Financial LLC bought a new stake in shares of CapsoVision in the fourth quarter valued at about $128,000. Millennium Management LLC bought a new position in CapsoVision during the 4th quarter worth about $163,000. State Street Corp grew its holdings in CapsoVision by 340.7% during the 4th quarter. State Street Corp now owns 85,929 shares of the company's stock worth $919,000 after acquiring an additional 66,429 shares in the last quarter. Wells Fargo &amp; Company MN increased its position in CapsoVision by 66.4% during the 4th quarter. Wells Fargo &amp; Company MN now owns 6,287 shares of the company's stock valued at $67,000 after purchasing an additional 2,508 shares during the period. Finally, Deutsche Bank AG bought a new stake in shares of CapsoVision in the 4th quarter valued at about $47,000.</p>
<div class="lb-trans"><p>几家机构投资者最近对该公司的持仓进行了调整。Virtu Financial LLC 在第四季度购买了 CapsoVision 的新股份，价值约 128,000 美元。Millennium Management LLC 在第四季度购买了 CapsoVision 的新持仓，价值约 163,000 美元。State Street Corp 在第四季度将其在 CapsoVision 的持股增加了 340.7%。State Street Corp 目前拥有 85,929 股该公司的股票，价值 919,000 美元，此前在上个季度增持了 66,429 股。Wells Fargo &amp; Company MN 在第四季度将其在 CapsoVision 的持仓增加了 66.4%。Wells Fargo &amp; Company MN 目前拥有 6,287 股该公司的股票，价值 67,000 美元，此前在此期间增持了 2,508 股。最后，德意志银行在第四季度购买了 CapsoVision 的新股份，价值约 47,000 美元。</p>
</div><h2>CapsoVision Company Profile</h2>
<div class="lb-trans"><h2>CapsoVision 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>CapsoVision, Inc NASDAQ: CV is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.</p>
<div class="lb-trans"><p>CapsoVision, Inc. 纳斯达克：CV 是一家医疗设备公司，专注于用于胃肠道诊断的先进胶囊内窥镜系统。该公司的旗舰产品 CapsoCam® Plus 系统，配备了四个侧视摄像头的可吞咽、无绳胶囊，能够捕捉小肠的高分辨率 360 度图像。通过内部存储图像而不是无线传输数据，CapsoCam Plus 使患者在手术期间能够保持正常的日常活动，并降低信号丢失或图像掉落的风险。</p>
</div><p>In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.</p>
<div class="lb-trans"><p>除了胶囊硬件外，CapsoVision 还提供 CapsoCloud®，一个安全的基于云的平台，简化图像检索、存储和报告。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than CapsoVision</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 CapsoVision</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CapsoVision Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CapsoVision 吗？</h2>
</div><p>Before you consider CapsoVision, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 CapsoVision 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CapsoVision wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而 CapsoVision 并不在名单上。</p>
</div><p>While CapsoVision currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CapsoVision 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

CapsoVision, Inc.（NASDAQ:CV）的空头头寸增加了 35.2%